ONEMEDNET CORPORATION APIC, Share-based Payment Arrangement, Increase for Cost Recognition
ONEMEDNET CORPORATION (ONMD) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $463.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-14
- ONEMEDNET CORPORATION apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $463.00K, a 135.03% increase year-over-year.
- ONEMEDNET CORPORATION apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $431.00K, a 107.21% increase year-over-year.
- ONEMEDNET CORPORATION apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $142.00K, a 31.40% decline year-over-year.
- ONEMEDNET CORPORATION apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $197.00K, a 91.26% increase year-over-year.
- ONEMEDNET CORPORATION apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $1.48M, a 20.91% decline from fiscal 2022.
- ONEMEDNET CORPORATION apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $1.86M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $463.00K 10-Q · filed 2026-08-14 | $894.00K derived: sum of 2 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $431.00K 10-Q · filed 2026-08-14 | |||||
| 2025-12-31 | $1.96M S-1/A · filed 2026-07-08 | |||||
| 2025-09-30 | $142.00K 10-Q · filed 2025-11-14 | $339.00K derived: sum of 2 quarters · filed 2026-08-14 | $547.00K derived: sum of 3 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $197.00K 10-Q · filed 2026-08-14 | $405.00K derived: sum of 2 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $208.00K 10-Q · filed 2026-08-14 | |||||
| 2024-12-31 | $628.00K S-1/A · filed 2026-07-08 | |||||
| 2024-09-30 | $207.00K 10-Q · filed 2025-11-14 | $310.00K derived: sum of 2 quarters · filed 2025-11-14 | $447.00K derived: sum of 3 quarters · filed 2025-11-14 | $476.00K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $103.00K 10-Q · filed 2025-11-14 | $240.00K derived: sum of 2 quarters · filed 2025-11-14 | $269.00K derived: sum of 3 quarters · filed 2025-11-14 | $1.07M derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-03-31 | $137.00K 10-Q · filed 2025-11-14 | $166.00K derived: sum of 2 quarters · filed 2025-11-14 | $964.00K derived: sum of 3 quarters · filed 2025-11-14 | $1.24M derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2023-12-31 | $29.00K derived: 10-K 12 month − 8-K/A 9 month · filed 2025-04-15 | $827.00K derived: sum of 2 quarters · filed 2025-04-15 | $1.11M derived: sum of 3 quarters · filed 2025-04-15 | $1.48M 10-K · filed 2025-04-15 | $1.89M 10-K · filed 2024-04-09 | |
| 2023-09-30 | $798.00K 10-Q · filed 2024-12-17 | $367.81K 10-Q · filed 2023-11-20 | $1.08M derived: sum of 2 quarters · filed 2024-12-17 | $1.45M 8-K/A · filed 2024-11-22 | $1.82M derived: sum of 4 quarters · filed 2024-12-17 | |
| 2023-06-30 | $280.00K 10-Q · filed 2024-12-17 | $504.82K 10-Q · filed 2023-11-20 | $1.03M derived: sum of 3 quarters · filed 2024-12-17 | $1.38M derived: sum of 4 quarters · filed 2024-12-17 | ||
| 2023-03-31 | $368.00K 10-Q · filed 2024-12-17 | $747.00K derived: sum of 2 quarters · filed 2024-12-17 | $1.10M derived: sum of 3 quarters · filed 2024-12-17 | |||
| 2022-12-31 | $379.00K derived: 10-K/A 12 month − 8-K/A 9 month · filed 2024-11-05 | $730.00K derived: sum of 2 quarters · filed 2024-11-22 | $1.86M 10-K/A · filed 2024-11-05 | $1.39M 10-Q · filed 2023-11-20 | ||
| 2022-09-30 | $351.00K 8-K/A · filed 2024-11-22 | $1.49M 8-K/A · filed 2024-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |